Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
☒ | Accelerated filer | ☐ | ||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||
Emerging growth company |
Item Number | Page | |||||||
1 | Financial Statements | |||||||
2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | |||||||
3 | Quantitative and Qualitative Disclosures About Market Risk | |||||||
4 | Controls and Procedures | |||||||
1 | Legal Proceedings | |||||||
1A | Risk Factors | |||||||
2 | Unregistered Sales of Equity Securities and Use of Proceeds | |||||||
3 | Defaults Upon Senior Securities | |||||||
4 | Mine Safety Disclosures | |||||||
5 | Other Information | |||||||
6 | Exhibits | |||||||
Signatures |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions, except per share amounts) | |||||||||||
Net sales | $ | $ | |||||||||
Operating costs and expenses: | |||||||||||
Cost of sales (exclusive of items shown separately below) | |||||||||||
Selling, general and administrative expense | |||||||||||
Depreciation and amortization | |||||||||||
Other expense, net | |||||||||||
Legal matters | |||||||||||
Other | |||||||||||
Total operating costs and expenses | |||||||||||
Operating income | |||||||||||
Non-operating: | |||||||||||
Retirement benefits expense | |||||||||||
Loss on debt | |||||||||||
Interest income and other | ( | ||||||||||
Interest expense | |||||||||||
Total non-operating expense, net | |||||||||||
Income before income taxes | |||||||||||
Income tax provision | |||||||||||
Net income | $ | $ | |||||||||
Earnings per share of common stock | |||||||||||
Basic earnings per share | $ | $ | |||||||||
Diluted | |||||||||||
Diluted earnings per share | $ | $ | |||||||||
Weighted average shares of common stock outstanding, basic | |||||||||||
Weighted average shares of common stock outstanding, diluted | |||||||||||
Cash dividends paid per share | $ | $ |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Net income | $ | $ | |||||||||
Other comprehensive income: | |||||||||||
Amortization of net actuarial losses and prior service costs, net of income taxes of $ | |||||||||||
Comprehensive income | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions, except per share amounts) | |||||||||||
ASSETS | |||||||||||
Current Assets | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash | |||||||||||
Marketable securities | |||||||||||
Accounts receivable | |||||||||||
Contract assets | |||||||||||
Other current assets | |||||||||||
Total Current Assets | |||||||||||
Noncurrent Assets | |||||||||||
Right-of-use assets | |||||||||||
Property, plant and equipment, net | |||||||||||
Recoverable environmental remediation costs | |||||||||||
Deferred income taxes | |||||||||||
Goodwill | |||||||||||
Intangible assets | |||||||||||
Other noncurrent assets | |||||||||||
Total Noncurrent Assets | |||||||||||
Total Assets | $ | $ | |||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current Liabilities | |||||||||||
Current portion of long-term debt | $ | $ | |||||||||
Accounts payable | |||||||||||
Reserves for environmental remediation costs | |||||||||||
Contract liabilities | |||||||||||
Other current liabilities | |||||||||||
Total Current Liabilities | |||||||||||
Noncurrent Liabilities | |||||||||||
Long-term debt | |||||||||||
Reserves for environmental remediation costs | |||||||||||
Pension benefits | |||||||||||
Operating lease liabilities | |||||||||||
Other noncurrent liabilities | |||||||||||
Total Noncurrent Liabilities | |||||||||||
Total Liabilities | |||||||||||
Commitments and contingencies (Note 8) | |||||||||||
Stockholders’ Equity | |||||||||||
Preferred stock, par value of $ | |||||||||||
Common stock, par value of $ | |||||||||||
Other capital | |||||||||||
Treasury stock at cost, | ( | ( | |||||||||
Retained earnings | |||||||||||
Accumulated other comprehensive loss, net of income taxes | ( | ( | |||||||||
Total Stockholders’ Equity | |||||||||||
Total Liabilities and Stockholders’ Equity | $ | $ |
Common Stock | (Accumulated Deficit) | Accumulated Other | Total | ||||||||||||||||||||||||||||||||||||||
Shares | Amount | Other Capital | Treasury Stock | Retained Earnings | Comprehensive Loss | Stockholders' Equity | |||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||
December 31, 2020 | $ | $ | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Amortization of net actuarial losses and prior service costs, net of income taxes | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Adjustment to dividends paid | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Settlement of debt | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||||
Repurchase of shares for withholding taxes and option costs under equity plans | — | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||
Stock-based compensation and shares issued under equity plans | — | — | — | — | |||||||||||||||||||||||||||||||||||||
March 31, 2021 | $ | $ | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||
December 31, 2021 | $ | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Amortization of net actuarial losses and prior service costs, net of income taxes | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
— | ( | — | ( | — | ( | ||||||||||||||||||||||||||||||||||||
Repurchase of shares for withholding taxes and option costs under equity plans | ( | — | ( | — | — | — | ( | ||||||||||||||||||||||||||||||||||
Stock-based compensation and shares issued under equity plans | — | — | — | — | |||||||||||||||||||||||||||||||||||||
March 31, 2022 | $ | $ | $ | ( | $ | $ | ( | $ |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Operating Activities | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash used in operating activities: | |||||||||||
Depreciation and amortization | |||||||||||
Amortization of debt discount and deferred financing costs | |||||||||||
Stock-based compensation | ( | ||||||||||
Retirement benefits, net | ( | ( | |||||||||
Loss on debt | |||||||||||
Other, net | ( | ||||||||||
Changes in assets and liabilities: | |||||||||||
Accounts receivable | ( | ( | |||||||||
Contract assets | ( | ( | |||||||||
Other current assets | |||||||||||
Recoverable environmental remediation costs | |||||||||||
Other noncurrent assets | |||||||||||
Accounts payable | ( | ( | |||||||||
Contract liabilities | |||||||||||
Other current liabilities | |||||||||||
Deferred income taxes | ( | ( | |||||||||
Reserves for environmental remediation costs | ( | ( | |||||||||
Other noncurrent liabilities and other | ( | ||||||||||
Net Cash Used in Operating Activities | ( | ( | |||||||||
Investing Activities | |||||||||||
Purchases of marketable securities | ( | ||||||||||
Capital expenditures | ( | ( | |||||||||
Net Cash Used in Investing Activities | ( | ( | |||||||||
Financing Activities | |||||||||||
Dividend payments | ( | ( | |||||||||
Debt repayments | ( | ( | |||||||||
Repurchase of shares for withholding taxes and option costs under equity plans | ( | ( | |||||||||
Proceeds from shares issued under equity plans | |||||||||||
Net Cash Used in Financing Activities | ( | ( | |||||||||
Net Decrease in Cash, Cash Equivalents and Restricted Cash | ( | ( | |||||||||
Cash, Cash Equivalents and Restricted Cash at Beginning of Period | |||||||||||
Cash, Cash Equivalents and Restricted Cash at End of Period | $ | $ | |||||||||
Supplemental disclosures of cash flow information | |||||||||||
Cash paid for interest | $ | $ | |||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions, except per share amounts) | |||||||||||
Numerator: | |||||||||||
Net income | $ | $ | |||||||||
Income allocated to participating securities | ( | ( | |||||||||
Net income for basic EPS | $ | $ | |||||||||
Interest on 2¼% Notes | |||||||||||
Net income for diluted EPS | $ | $ | |||||||||
Denominator: | |||||||||||
Basic weighted average shares | |||||||||||
Effect of: | |||||||||||
21/4% Notes | |||||||||||
Diluted weighted average shares | |||||||||||
Basic | |||||||||||
Basic EPS | $ | $ | |||||||||
Diluted | |||||||||||
Diluted EPS | $ | $ |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions, except per share amounts) | |||||||||||
Net unfavorable effect of the changes in contract estimates on net sales | $ | ( | $ | ( | |||||||
Net unfavorable effect of the changes in contract estimates on income before income taxes | ( | ( | |||||||||
Net unfavorable effect of the changes in contract estimates on net income | ( | ( | |||||||||
Net unfavorable effect of the changes in contract estimates on basic and diluted EPS | ( | ( | |||||||||
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions) | |||||||||||
Contract assets | $ | $ | |||||||||
Reserve for overhead rate disallowance | ( | ( | |||||||||
Contract assets, net of reserve | |||||||||||
Contract liabilities | |||||||||||
Net contract assets (liabilities), net of reserve | $ | $ | ( | ||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
Fixed-price | % | % | |||||||||
Cost-reimbursable | |||||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
U.S. government | % | % | |||||||||
Non U.S. government | |||||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Stock Appreciation Rights | $ | ( | $ | ( | |||||||
Restricted stock and restricted stock units, service based | |||||||||||
Restricted stock and restricted stock units, performance based | |||||||||||
Employee stock purchase plan | |||||||||||
Total stock-based compensation (benefit) expense | $ | ( | $ |
Fair value measurement as of March 31, 2022 | |||||||||||||||||||||||
Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other Observable Inputs (Level 2) | Unobservable Inputs (Level 3) | ||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Money market funds | $ | $ | $ | $ | |||||||||||||||||||
Registered investment companies | |||||||||||||||||||||||
Commercial paper | |||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||
Total | $ | $ | $ | $ |
Fair value measurement as of December 31, 2021 | |||||||||||||||||||||||
Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other Observable Inputs (Level 2) | Unobservable Inputs (Level 3) | ||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Money market funds | $ | $ | $ | $ | |||||||||||||||||||
Registered investment companies | |||||||||||||||||||||||
Commercial paper | |||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||
Total | $ | $ | $ | $ |
Fair Value | Principal Amount | ||||||||||||||||||||||
March 31, 2022 | December 31, 2021 | March 31, 2022 | December 31, 2021 | ||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Term loan | $ | $ | $ | $ | |||||||||||||||||||
21/4% Notes | |||||||||||||||||||||||
Total | $ | $ | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions) | |||||||||||
Billed receivables under long-term contracts | $ | $ | |||||||||
Other trade receivables | |||||||||||
Accounts receivable | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions) | |||||||||||
Deferred costs recoverable from the U.S. government | $ | $ | |||||||||
Income tax receivable | |||||||||||
Inventories | |||||||||||
Prepaid expenses | |||||||||||
Other | |||||||||||
Other current assets | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions) | |||||||||||
Land | $ | $ | |||||||||
Buildings and improvements | |||||||||||
Machinery and equipment, including capitalized software | |||||||||||
Construction-in-progress | |||||||||||
Less: accumulated depreciation | ( | ( | |||||||||
Property, plant and equipment, net | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions) | |||||||||||
Real estate held for entitlement and leasing | $ | $ | |||||||||
Deferred costs recoverable from the U.S. government | |||||||||||
Receivable from Northrop Grumman Corporation for environmental remediation costs | |||||||||||
Other | |||||||||||
Other noncurrent assets | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions) | |||||||||||
Accrued compensation and employee benefits | $ | $ | |||||||||
Income taxes payable | |||||||||||
Other | |||||||||||
Other current liabilities | $ | $ |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Income tax provision | $ | $ | |||||||||
March 31, 2022 | December 31, 2021 | ||||||||||
(In millions) | |||||||||||
Term loan, bearing interest at variable rates (rate of | $ | $ | |||||||||
Unamortized deferred financing costs | ( | ( | |||||||||
Total senior debt | |||||||||||
Convertible senior notes, bearing interest at | |||||||||||
Unamortized discount and deferred financing costs | ( | ( | |||||||||
Total convertible senior notes | |||||||||||
Finance leases | |||||||||||
Total other debt | |||||||||||
Total debt, net of unamortized discount and deferred financing costs | |||||||||||
Less: Amounts due within one year | ( | ( | |||||||||
Total long-term debt, net of unamortized discount and deferred financing costs | $ | $ |
March 31, 2022 | December 31, 2021 | ||||||||||
Remaining amortization period (years) | |||||||||||
Effective interest rate | % | % | |||||||||
Conversion rate (shares of common stock per $1,000 principal amount) | 38.4615 | 38.4615 | |||||||||
Conversion price (per share of common stock) | $ | $ |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Interest expense-contractual interest | $ | $ | |||||||||
Interest expense-amortization of debt discount (see discussion above) | |||||||||||
Interest expense-amortization of deferred financing costs |
Aerojet Rocketdyne- Sacramento | Aerojet Rocketdyne- BPOU | Other Aerojet Rocketdyne Sites | Total Aerojet Rocketdyne | Other | Total Environmental Reserve | ||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
December 31, 2021 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Additions/Adjustments | ( | ||||||||||||||||||||||||||||||||||
Expenditures | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
March 31, 2022 | $ | $ | $ | $ | $ | $ |
Total reimbursable costs under the Northrop Agreement | $ | ||||
Amount reimbursed to the Company through March 31, 2022 | ( | ||||
Receivable from Northrop included in the unaudited balance sheet at March 31, 2022 | $ | ||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Expense to unaudited condensed consolidated statements of operations | $ | $ | |||||||||
Pension Benefits | Postretirement Medical and Life Insurance Benefits | ||||||||||||||||||||||
Three months ended March 31, | |||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Interest cost on benefit obligation | $ | $ | $ | $ | |||||||||||||||||||
Expected return on assets | ( | ( | |||||||||||||||||||||
Amortization of net losses (gains) | ( | ( | |||||||||||||||||||||
Retirement benefits expense (income) | $ | $ | $ | ( | $ | ( |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Net Sales: | |||||||||||
Aerospace and Defense | $ | $ | |||||||||
Real Estate | |||||||||||
Total Net Sales | $ | $ | |||||||||
Segment Performance: | |||||||||||
Aerospace and Defense | $ | $ | |||||||||
Environmental remediation provision adjustments | ( | ( | |||||||||
GAAP/Cost Accounting Standards retirement benefits expense difference | |||||||||||
Unusual items (see Note 11) | ( | ( | |||||||||
Aerospace and Defense Total | |||||||||||
Real Estate | ( | ( | |||||||||
Total Segment Performance | $ | $ | |||||||||
Reconciliation of segment performance to income before income taxes: | |||||||||||
Segment performance | $ | $ | |||||||||
Interest expense | ( | ( | |||||||||
Interest income and other | ( | ||||||||||
Stock-based compensation | ( | ||||||||||
Corporate retirement benefits | ( | ||||||||||
Corporate and other | ( | ( | |||||||||
Unusual items (see Note 11) | ( | ( | |||||||||
Income before income taxes | $ | $ | |||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
Lockheed Martin | % | % | |||||||||
NASA | |||||||||||
Raytheon Technologies Corporation | |||||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Unusual items | |||||||||||
Legal matters (component of other expense, net) | $ | $ | |||||||||
Proxy contest and related litigation costs (component of other expense, net) | |||||||||||
Terminated merger costs (component of other expense, net) | |||||||||||
Loss on debt | |||||||||||
$ | $ |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Legal | $ | $ | |||||||||
Employee compensation | |||||||||||
Consulting and other professional costs | |||||||||||
$ | $ |
As of December 31, 2021 | |||||||||||||||||
As Reported | Adjustments | As Revised | |||||||||||||||
(In millions) | |||||||||||||||||
ASSETS | |||||||||||||||||
Current Assets | |||||||||||||||||
Cash and cash equivalents | $ | $ | $ | ||||||||||||||
Restricted cash | |||||||||||||||||
Marketable securities | |||||||||||||||||
Accounts receivable, net | |||||||||||||||||
Contract assets | |||||||||||||||||
Other current assets, net | ( | ||||||||||||||||
Total Current Assets | ( | ||||||||||||||||
Noncurrent Assets | |||||||||||||||||
Right-of-use assets | |||||||||||||||||
Property, plant and equipment, net | |||||||||||||||||
Recoverable environmental remediation costs | |||||||||||||||||
Deferred income taxes | ( | ||||||||||||||||
Goodwill | |||||||||||||||||
Intangible assets | |||||||||||||||||
Other noncurrent assets, net | |||||||||||||||||
Total Noncurrent Assets | ( | ||||||||||||||||
Total Assets | $ | $ | ( | $ | |||||||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||
Current Liabilities | |||||||||||||||||
Current portion of long-term debt | $ | $ | $ | ||||||||||||||
Accounts payable | |||||||||||||||||
Reserves for environmental remediation costs | |||||||||||||||||
Contract liabilities | |||||||||||||||||
Other current liabilities | |||||||||||||||||
Total Current Liabilities | |||||||||||||||||
Noncurrent Liabilities | |||||||||||||||||
Long-term debt | |||||||||||||||||
Reserves for environmental remediation costs | |||||||||||||||||
Pension benefits | |||||||||||||||||
Operating lease liabilities | |||||||||||||||||
Other noncurrent liabilities | |||||||||||||||||
Total Noncurrent Liabilities | |||||||||||||||||
Total Liabilities | |||||||||||||||||
Commitments and contingencies (Note 8) | |||||||||||||||||
Stockholders’ Equity | |||||||||||||||||
Common stock | |||||||||||||||||
Other capital | ( | ||||||||||||||||
Treasury stock at cost | ( | ( | |||||||||||||||
Retained earnings | |||||||||||||||||
Accumulated other comprehensive loss, net of income taxes | ( | ( | |||||||||||||||
Total Stockholders’ Equity | ( | ||||||||||||||||
Total Liabilities and Stockholders’ Equity | $ | $ | ( | $ |
Three Months Ended March 31, 2021 | |||||||||||||||||
As Reported | Adjustments | As Revised | |||||||||||||||
(In millions) | |||||||||||||||||
Common stock | $ | $ | $ | ||||||||||||||
Other capital | ( | ||||||||||||||||
Treasury stock | ( | ( | |||||||||||||||
Accumulated deficit | ( | ( | |||||||||||||||
Accumulated other comprehensive loss | ( | ( | |||||||||||||||
Total stockholders' equity | $ | $ | ( | $ |
Three Months Ended March 31, 2021 | |||||||||||||||||
As Reported | Adjustments | As Revised | |||||||||||||||
(In millions) | |||||||||||||||||
Operating Activities | |||||||||||||||||
Net income | $ | $ | $ | ||||||||||||||
Adjustments to reconcile net income to net cash used in operating activities: | |||||||||||||||||
Depreciation and amortization | |||||||||||||||||
Amortization of debt discount and deferred financing costs | |||||||||||||||||
Stock-based compensation | |||||||||||||||||
Retirement benefits, net | ( | ( | |||||||||||||||
Loss on debt | |||||||||||||||||
Other, net | ( | ( | |||||||||||||||
Changes in assets and liabilities: | |||||||||||||||||
Accounts receivable, net | ( | ( | |||||||||||||||
Contract assets | ( | ( | |||||||||||||||
Other current assets, net | |||||||||||||||||
Recoverable environmental remediation costs | |||||||||||||||||
Other noncurrent assets | |||||||||||||||||
Accounts payable | ( | ( | |||||||||||||||
Contract liabilities | |||||||||||||||||
Other current liabilities | |||||||||||||||||
Deferred income taxes | ( | ( | |||||||||||||||
Reserves for environmental remediation costs | ( | ( | |||||||||||||||
Other noncurrent liabilities and other | |||||||||||||||||
Net Cash Used in Operating Activities | ( | ( | |||||||||||||||
Investing Activities | |||||||||||||||||
Net Cash Used in Investing Activities | ( | ( | |||||||||||||||
Financing Activities | |||||||||||||||||
Net Cash Used in Financing Activities | ( | ( | |||||||||||||||
Net Decrease in Cash, Cash Equivalents and Restricted Cash | ( | ( | |||||||||||||||
Cash, Cash Equivalents and Restricted Cash at Beginning of Year | |||||||||||||||||
Cash, Cash Equivalents and Restricted Cash at End of Year | $ | $ | $ |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions, except percentage and per share amounts) | |||||||||||
Net sales | $ | 511.1 | $ | 496.1 | |||||||
Net income | 27.8 | 18.1 | |||||||||
Net income as a percentage of net sales | 5.4 | % | 3.6 | % | |||||||
Adjusted Net Income (Non-GAAP measure*) | 36.9 | 29.3 | |||||||||
Adjusted Net Income (Non-GAAP measure*) as a percentage of net sales | 7.2 | % | 5.9 | % | |||||||
Earnings Per Share ("EPS") - Diluted | 0.33 | 0.22 | |||||||||
Adjusted EPS (Non-GAAP measure*) | 0.44 | 0.36 | |||||||||
Adjusted EBITDAP (Non-GAAP measure*) | 69.3 | 58.5 | |||||||||
Adjusted EBITDAP (Non-GAAP measure*) as a percentage of net sales | 13.6 | % | 11.8 | % | |||||||
Cash used in operating activities | (75.0) | (69.4) | |||||||||
Free cash flow (Non-GAAP measure*) | (77.2) | (73.2) |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
U.S. government | 95 | % | 97 | % | |||||||
Non U.S. government | 5 | 3 | |||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
RS-25 | 15 | % | 22 | % | |||||||
Standard Missile | 12 | 12 | |||||||||
Patriot Advanced Capability-3 ("PAC-3") | 12 | 6 | |||||||||
Terminal High Altitude Area Defense ("THAAD") | 8 | 9 |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
Lockheed Martin | 34 | % | 27 | % | |||||||
NASA | 18 | 26 | |||||||||
Raytheon Technologies Corporation | 17 | 15 | |||||||||
Recoverable Amounts (1) | Environmental Reserves | Estimated Range of Liability | |||||||||||||||
(In millions) | |||||||||||||||||
Sacramento | $ | 189.4 | $ | 215.2 | $215.2 - $349.2 | ||||||||||||
Baldwin Park Operable Unit | 54.2 | 61.6 | 61.6 - 74.3 | ||||||||||||||
Other Aerojet Rocketdyne sites | 11.7 | 11.7 | 11.7 - 21.3 | ||||||||||||||
Other sites | 0.7 | 5.2 | 5.2 - 6.4 | ||||||||||||||
Total | $ | 256.0 | $ | 293.7 | $293.7 - $451.2 |
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions) | |||||||||||||||||
Net sales | $ | 511.1 | $ | 496.1 | $ | 15.0 | |||||||||||
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions, except percentage amounts) | |||||||||||||||||
Cost of sales (exclusive of items shown separately below) | $ | 425.5 | $ | 418.0 | $ | 7.5 | |||||||||||
Percentage of net sales | 83.3 | % | 84.3 | % |
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions, except percentage amounts) | |||||||||||||||||
Components of SG&A: | |||||||||||||||||
SG&A excluding stock-based compensation | $ | 9.1 | $ | 6.2 | $ | 2.9 | |||||||||||
Stock-based compensation | (0.9) | 2.8 | (3.7) | ||||||||||||||
SG&A | $ | 8.2 | $ | 9.0 | $ | (0.8) | |||||||||||
Percentage of net sales | 1.6 | % | 1.8 | % | |||||||||||||
Percentage of net sales excluding stock-based compensation | 1.8 | % | 1.2 | % | |||||||||||||
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions) | |||||||||||||||||
Components of depreciation and amortization: | |||||||||||||||||
Depreciation | $ | 12.0 | $ | 11.2 | $ | 0.8 | |||||||||||
Amortization | 1.7 | 3.3 | (1.6) | ||||||||||||||
Accretion | 0.7 | 0.7 | — | ||||||||||||||
Depreciation and amortization | $ | 14.4 | $ | 15.2 | $ | (0.8) |
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions) | |||||||||||||||||
Other expense, net | $ | 20.3 | $ | 8.1 | $ | 12.2 | |||||||||||
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions) | |||||||||||||||||
Components of retirement benefits expense: | |||||||||||||||||
Interest cost on benefit obligation | $ | 9.0 | $ | 8.5 | $ | 0.5 | |||||||||||
Expected return on assets | (15.7) | (15.3) | (0.4) | ||||||||||||||
Amortization of prior service costs | — | — | — | ||||||||||||||
Amortization of net losses | 7.0 | 15.3 | (8.3) | ||||||||||||||
Retirement benefits expense | $ | 0.3 | $ | 8.5 | $ | (8.2) |
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions) | |||||||||||||||||
Loss on debt | $ | — | $ | 9.1 | $ | (9.1) |
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions) | |||||||||||||||||
Interest income and other | $ | (0.2) | $ | 0.6 | $ | (0.8) |
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions) | |||||||||||||||||
Components of interest expense: | |||||||||||||||||
Contractual interest and other | $ | 3.5 | $ | 3.6 | $ | (0.1) | |||||||||||
Amortization of debt discount and deferred financing costs | 0.4 | 1.5 | (1.1) | ||||||||||||||
Interest expense | $ | 3.9 | $ | 5.1 | $ | (1.2) |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Income tax provision | $ | 10.5 | $ | 5.6 | |||||||
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change* | |||||||||||||||
(In millions, except percentage amounts) | |||||||||||||||||
Net sales | $ | 510.5 | $ | 495.5 | $ | 15.0 | |||||||||||
Segment performance | 55.2 | 53.5 | 1.7 | ||||||||||||||
Segment margin | 10.8 | % | 10.8 | % | |||||||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
Fixed-price | 56 | % | 51 | % | |||||||
Cost-reimbursable | 44 | 49 | |||||||||
Three months ended March 31, | |||||||||||||||||
2022 | 2021 | Change | |||||||||||||||
(In millions) | |||||||||||||||||
Net sales | $ | 0.6 | $ | 0.6 | $ | — | |||||||||||
Segment performance | (0.1) | (0.3) | 0.2 |
March 31, 2022 | December 31, 2021 | ||||||||||
(In billions) | |||||||||||
Funded backlog | $ | 2.8 | $ | 3.1 | |||||||
Unfunded backlog | 3.6 | 3.7 | |||||||||
Total backlog | $ | 6.4 | $ | 6.8 |
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions, except per share and percentage amounts) | |||||||||||
Net income | $ | 27.8 | $ | 18.1 | |||||||
Interest expense | 3.9 | 5.1 | |||||||||
Interest income and other | 0.2 | (0.6) | |||||||||
Income tax provision | 10.5 | 5.6 | |||||||||
Depreciation and amortization | 14.4 | 15.2 | |||||||||
GAAP retirement benefits expense | 0.3 | 8.5 | |||||||||
CAS recoverable retirement benefits expense | (9.5) | (10.0) | |||||||||
Unusual items | 21.7 | 16.6 | |||||||||
Adjusted EBITDAP | $ | 69.3 | $ | 58.5 | |||||||
Net income as a percentage of net sales | 5.4 | % | 3.6 | % | |||||||
Adjusted EBITDAP as a percentage of net sales | 13.6 | % | 11.8 | % | |||||||
Net income | $ | 27.8 | $ | 18.1 | |||||||
GAAP retirement benefits expense | 0.3 | 8.5 | |||||||||
CAS recoverable retirement benefits expense | (9.5) | (10.0) | |||||||||
Unusual items | 21.7 | 16.6 | |||||||||
Income tax impact of adjustments (1) | (3.4) | (3.9) | |||||||||
Adjusted Net Income | $ | 36.9 | $ | 29.3 | |||||||
Diluted EPS | $ | 0.33 | $ | 0.22 | |||||||
Adjustments | 0.11 | 0.14 | |||||||||
Adjusted EPS | $ | 0.44 | $ | 0.36 | |||||||
Diluted weighted average shares, as reported and adjusted | 85.8 | 80.7 | |||||||||
Three months ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
(In millions) | |||||||||||
Net cash used in operating activities | $ | (75.0) | $ | (69.4) | |||||||
Capital expenditures | (2.2) | (3.8) | |||||||||
Free Cash Flow | $ | (77.2) | $ | (73.2) | |||||||
December 31, 2021 | Cash Payments | March 31, 2022 | |||||||||||||||
(In millions) | |||||||||||||||||
Term loan | $ | 282.2 | $ | (6.6) | $ | 275.6 | |||||||||||
2 1/4% Notes | 145.9 | — | 145.9 | ||||||||||||||
Finance leases | 43.4 | (0.5) | 42.9 | ||||||||||||||
Total debt activity | $ | 471.5 | $ | (7.1) | $ | 464.4 |
Fair Value | Principal Amount | ||||||||||||||||||||||
March 31, 2022 | December 31, 2021 | March 31, 2022 | December 31, 2021 | ||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Term loan | $ | 269.8 | $ | 275.8 | $ | 275.6 | $ | 282.2 | |||||||||||||||
21/4% Notes | 229.9 | 266.1 | 145.9 | 145.9 | |||||||||||||||||||
Total | $ | 499.7 | $ | 541.9 | $ | 421.5 | $ | 428.1 | |||||||||||||||
Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased under the Plans or Programs | ||||||||||||||||||||||
January 1, 2022 through January 31, 2022 | 310 | $ | 46.15 | — | — | |||||||||||||||||||||
February 1, 2022 through February 28, 2022 | 100,043 | 38.75 | — | — | ||||||||||||||||||||||
March 1, 2022 through March 31, 2022 | — | — | — | — | ||||||||||||||||||||||
Total | 100,353 | $ | 38.77 | — | — |
Incorporated herein by reference | ||||||||||||||||||||||||||||||||||||||
Table Item No. | Exhibit Description | Form | File Number | Exhibit | Filing Date | Filed or Furnished herewith | ||||||||||||||||||||||||||||||||
31.1 | X | |||||||||||||||||||||||||||||||||||||
31.2 | X | |||||||||||||||||||||||||||||||||||||
32.1 | X | |||||||||||||||||||||||||||||||||||||
101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | ||||||||||||||||||||||||||||||||||||
101.SCH | XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||||||||||||||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||||||||||||||||||||
104 | Cover Page Interactive Data File (included as Exhibit 101) -- the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X |
Aerojet Rocketdyne Holdings, Inc. | ||||||||||||||
Date: | May 3, 2022 | By: | /s/ Eileen P. Drake | |||||||||||
Eileen P. Drake | ||||||||||||||
Chief Executive Officer and President | ||||||||||||||
(Principal Executive Officer) | ||||||||||||||
Date: | May 3, 2022 | By: | /s/ Daniel L. Boehle | |||||||||||
Daniel L. Boehle | ||||||||||||||
Vice President and Chief Financial Officer | ||||||||||||||
(Principal Financial Officer and Principal Accounting Officer) | ||||||||||||||
/s/ Eileen P. Drake | ||
Eileen P. Drake | ||
Chief Executive Officer and President | ||
(Principal Executive Officer) |
/s/ Daniel L. Boehle | ||
Daniel L. Boehle | ||
Vice President and Chief Financial Officer | ||
(Principal Financial Officer and Principal Accounting Officer) |
/s/ Eileen P. Drake | ||
Eileen P. Drake | ||
Chief Executive Officer and President | ||
(Principal Executive Officer) | ||
Date: May 3, 2022 |
/s/ Daniel L. Boehle | ||
Daniel L. Boehle | ||
Vice President and Chief Financial Officer | ||
(Principal Financial Officer and Principal Accounting Officer) | ||
Date: May 3, 2022 |
,OA3X\\
M*>!_AYXFNO#E]!:/J.K7%BP#OYAVPQ'(. CMCOO7TH _3*BOYX_^&\_V@O^
MBK^(/^_R?_$U[3X'\2?MV_$KPKI_B7PSJGC/5M"U!"]K>17%NJRJ&*D@,0<9
M4\DHR?6OH*B@#X[US_@E3\"?$
M>M7^K:C;>(KG4+ZXDNKB9]7
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 27.8 | $ 18.1 |
Other comprehensive income: | ||
Amortization of net actuarial losses and prior service costs, net of income taxes of $1.8 million and $3.8 million | 5.2 | 11.5 |
Comprehensive income | $ 33.0 | $ 29.6 |
Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Statement of Comprehensive Income [Abstract] | ||
Income taxes | $ 1.8 | $ 3.8 |
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Preference stock, par value (in USD per share) | $ 1.00 | $ 1.00 |
Preference stock, shares authorized (in shares) | 15.0 | 15.0 |
Preference stock, shares issued (in shares) | 0.0 | 0.0 |
Preference stock, shares outstanding (in shares) | 0.0 | 0.0 |
Common stock, par value (in USD per share) | $ 0.10 | $ 0.10 |
Common stock, shares authorized (in shares) | 150.0 | 150.0 |
Common stock, shares outstanding (in shares) | 80.3 | 80.1 |
Treasury stock, shares (in shares) | 2.1 | 2.1 |
Basis of Presentation and Nature of Operations |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Nature of Operations | Basis of Presentation and Nature of Operations Aerojet Rocketdyne Holdings, Inc. ("Aerojet Rocketdyne Holdings" or the "Company") has prepared the accompanying unaudited condensed consolidated financial statements, including the accounts of the Company and its 100% owned and majority owned subsidiaries, in accordance with the instructions to Form 10-Q. The December 31, 2021, condensed consolidated balance sheet was derived from audited financial statements, but does not include all of the disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). These interim financial statements should be read in conjunction with the financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Certain reclassifications have been made to financial information for prior years to conform to the current year’s presentation. The Company believes the accompanying unaudited condensed consolidated financial statements reflect all adjustments, including normal recurring accruals, necessary for a fair statement of its financial position, results of operations, and cash flows for the periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In addition, the operating results for interim periods may not be indicative of the results of operations for a full year. The Company’s operations are organized into two segments: Aerospace and Defense — includes the operations of the Company’s wholly-owned subsidiary Aerojet Rocketdyne, Inc. ("Aerojet Rocketdyne"), a leading technology-based designer, developer and manufacturer of aerospace and defense products and systems for the United States ("U.S.") government, including the Department of Defense ("DoD"), the National Aeronautics and Space Administration ("NASA"), and major aerospace and defense prime contractors. Real Estate — includes the activities of the Company’s wholly-owned subsidiary Easton Development Company, LLC ("Easton") related to the re-zoning, entitlement, sale, and leasing of the Company’s excess real estate assets. The fiscal year of the Company's subsidiary, Aerojet Rocketdyne, ends on the last Saturday in December. A detailed description of the Company’s significant accounting policies can be found in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2021. Revision of Previously Issued Consolidated Financial Statements During the three months ended March 31, 2022, the Company identified an error in its accounting for income taxes associated with its 2.25% Convertible Senior Notes ("2¼% Notes"). Upon issuance of the 2¼% Notes in 2016, the Company did not record the applicable deferred tax liability associated with the conversion option that had been recorded in other capital, which resulted in an overstatement of other capital, an understatement of deferred tax liabilities and an error in income tax expense in subsequent periods. The Company evaluated the errors and concluded that the errors were not material, either individually or in aggregate, to its current or previously issued consolidated financial statements. To correct the immaterial errors, the Company has revised its previously issued consolidated financial statements as of December 31, 2021 and 2020, and for each of the three years ended December 31, 2021, 2020, and 2019, and its unaudited condensed consolidated financial statements as of and for the quarters and year-to-date periods ended March 31, 2021, June 30, 2021, and September 30, 2021. The revision of the historical consolidated financial statements also includes the correction of an immaterial misclassification in its unaudited condensed consolidated balance sheet as of December 31, 2020. Accordingly, the accompanying financial statements and relevant footnotes to the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q have been revised to correct for such immaterial errors. See Note 12 for additional information. The Company will present the revision of its previously issued consolidated financial statements as of December 31, 2021, and for the years ended December 31, 2021 and 2020, in connection with the future filing of its 2022 Annual Report on Form 10-K. Additionally, the Company will present the revision of its previously issued condensed consolidated financial statements as of and for the three and six months ended June 30, 2021, and as of and for the three and nine months ended September 30, 2021, in connection with the future filings of its Quarterly Reports on Form 10-Q. Terminated Merger Agreement On December 20, 2020, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lockheed Martin Corporation ("Lockheed Martin") and Mizar Sub, Inc., a wholly-owned subsidiary of Lockheed Martin ("Merger Sub"), pursuant to which each share of common stock of the Company would have been automatically converted into the right to receive cash in an amount equal to $51.00 per share, adjusted from $56.00 following the payment of a one-time cash dividend of $5.00 per share paid in March 2021 (the "Pre-Closing Dividend") and the Company would have become a wholly-owned subsidiary of Lockheed Martin (the "Merger"). On January 25, 2022, the Federal Trade Commission ("FTC") filed a complaint against the Company and Lockheed Martin in the FTC’s administrative court and a complaint in U.S. federal court seeking a preliminary injunction to stop the deal pending an administrative trial (the "FTC Litigation"). On February 13, 2022, Lockheed Martin notified the Company that it had elected to terminate the Merger Agreement. On February 14, 2022, pursuant to the parties’ joint motion, the administrative complaint and the U.S. federal court complaint were dismissed. Coronavirus ("COVID-19") Pandemic During the three months ended March 31, 2022, the Company’s financial results and operations were not materially adversely impacted by the COVID-19 pandemic. The extent to which the Company’s future financial results could be impacted by the COVID-19 pandemic depends on future developments that are highly uncertain and cannot be predicted at this time. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Quarterly Report on Form 10-Q. These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions. Recently Issued Accounting Pronouncements In August 2020, the Financial Accounting Standards Board issued guidance which simplifies the accounting for convertible instruments. This guidance eliminates certain models that require separate accounting for embedded conversion features, in certain cases. Additionally, among other changes, the guidance eliminates certain of the conditions for equity classification for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The Company adopted the new guidance as of January 1, 2022, using the modified retrospective approach resulting in the following adjustment (i) a decrease of $1.9 million in deferred tax liabilities, (ii) a decrease of $5.6 million in other capital, (iii) a decrease of $1.0 million in retained earnings, and (iv) an increase of $8.5 million in debt.
|
Earnings Per Share ("EPS") of Common Stock |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share (EPS) of Common Stock | Earnings Per Share ("EPS") of Common Stock The following table reconciles the numerator and denominator used to calculate basic and diluted EPS of common stock:
Securities which would have been anti-dilutive are insignificant and are excluded from the computation of diluted earnings per share in all periods presented. The increase in the dilutive effect of the 2¼% Notes in the three months ended March 31, 2022, is the result of the adoption of new accounting guidance. See Note 1.
|
Revenue Recognition |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition | Revenue Recognition In the Company’s Aerospace and Defense segment, the majority of revenue is earned from long-term contracts to design, develop, and manufacture aerospace and defense products for, and provide related services to, the Company’s customers, including the U.S. government and major aerospace and defense prime contractors. The Company evaluates the contract value and cost estimates for performance obligations at least quarterly and more frequently when circumstances significantly change. Factors considered in estimating the work to be completed include, but are not limited to: labor productivity, the nature and technical complexity of the work to be performed, availability and cost volatility of materials, subcontractor and vendor performance, warranty costs, volume assumptions, anticipated labor agreements, inflationary trends, schedule and performance delays, availability of funding from the customer, and the recoverability of costs incurred outside the original contract included in any estimates to complete. When the Company’s estimate of total costs to be incurred to satisfy a performance obligation exceeds the expected revenue, the Company recognizes the loss immediately. When the Company determines that a change in estimates has an impact on the associated profit of a performance obligation, the Company records the cumulative positive or negative adjustment to the statement of operations. Changes in estimates and assumptions related to the status of certain long-term contracts may have a material effect on the Company’s operating results. The following table summarizes the impact of the changes in significant contract accounting estimates on the Company’s Aerospace and Defense segment operating results:
In the Company’s Aerospace and Defense segment, the timing of revenue recognition, customer invoicing, and collections produces accounts receivable, contract assets, and contract liabilities in the unaudited condensed consolidated balance sheets. The following table summarizes contract assets and liabilities:
Net contract assets increased by $17.6 million from December 31, 2021, primarily due to an increase in unbilled receivables. During the three months ended March 31, 2022, the Company recognized sales of $121.8 million that were included in the Company's contract liabilities as of December 31, 2021. As of March 31, 2022, the Company’s total remaining performance obligations, also referred to as backlog, totaled $6.4 billion. The Company expects to recognize approximately 37%, or $2.4 billion, of the remaining performance obligations as sales over the next twelve months, an additional 26% the following twelve months, and 37% thereafter. The Company's contracts are largely categorized as either "fixed-price" (largely used by the U.S. government for production-type contracts) or "cost-reimbursable" (largely used by the U.S. government for development-type contracts). Fixed-price contracts present the risk of unreimbursed cost overruns, potentially resulting in lower than expected contract profits and margins. This risk is generally lower for cost-reimbursable contracts which, as a result, generally have a lower margin. The following table summarizes the percentages of net sales by contract type:
The principal end user customers are primarily agencies of the U.S. government as illustrated in the following table:
|
Stock-Based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation | Stock-Based Compensation The following table summarizes stock-based compensation by type of award:
|
Balance Sheet Accounts |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Accounts | Balance Sheet Accounts a. Fair Value of Financial Instruments Financial instruments are classified using a three-tiered fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
As of March 31, 2022 and December 31, 2021, the total estimated fair value for commercial paper was classified as cash and cash equivalents as the remaining maturity at date of purchase was less than three months. The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued compensation, and other accrued liabilities, approximate fair value because of their short maturities. The following table summarizes the estimated fair value and principal amount for outstanding debt obligations excluding finance lease obligations:
The fair value of the 2¼% Notes was determined using broker quotes that are based on open markets for the Company's debt securities (Level 2 securities). The fair value of the term loan was estimated based on a third-party model used to derive a relative value price using comparable corporate loans within a similar industry, credit quality, and currency. b. Accounts Receivable
c. Other Current Assets
d. Property, Plant and Equipment, net
e. Other Noncurrent Assets
f. Other Current Liabilities
|
Income Taxes |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes | Income Taxes
In the three months ended March 31, 2022, the income tax provision was $10.5 million for an effective tax rate of 27.4%. The Company’s effective tax rate differed from the 21% statutory federal income tax rate primarily due to state income taxes and certain expenditures which are permanently not deductible for tax purposes, partially offset by the impact of R&D credits and original issue discount on convertible debt. In the three months ended March 31, 2021, the income tax provision was $5.6 million for an effective tax rate of 23.6%. The Company’s effective tax rate differed from the 21% statutory federal income tax rate primarily due to state income taxes and certain expenditures which are permanently not deductible for tax purposes, partially offset by the impact of R&D credits. A valuation allowance is required when it is more-likely-than-not that all or a portion of deferred tax assets may not be realized. Assessing the need for a valuation allowance requires management to evaluate, on a quarterly basis, all available evidence, both positive and negative. As of March 31, 2022, the Company continues to believe that the weight of the positive evidence outweighed the negative evidence regarding the realization of its net deferred tax assets.
|
Long-term Debt |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-term Debt | Long-term Debt
Senior Credit Facility The senior secured senior credit facility (the "Senior Credit Facility") matures on September 20, 2023, and consists of (i) a $650.0 million revolving line of credit (the "Revolver") and (ii) a $350.0 million term loan (the "Term Loan"). As of March 31, 2022, the Company had zero borrowings under the Revolver and issued $27.8 million in letters of credit. The Term Loan and any borrowings under the Revolver bear interest at LIBOR plus an applicable margin ranging from 175 to 250 basis points based on the Company's leverage ratio (the "Consolidated Net Leverage Ratio") measured at the end of each quarter. In addition to interest, the Company must pay certain fees including (i) letter of credit fees ranging from 175 to 250 basis points per annum on the amount of issued but undrawn letters of credit and eurocurrency rate loans and (ii) commitment fees ranging from 30 to 45 basis points per annum on the unused portion of the Revolver. The Term Loan amortized at a rate of 7.5% per annum as of March 31, 2022, and increasing to 10.0% per annum from December 31, 2022, to be paid in equal quarterly installments with any remaining amounts, along with outstanding borrowings under the Revolver, due on the maturity date. Outstanding borrowings under the Revolver and the Term Loan may be voluntarily repaid at any time, in whole or in part, without premium or penalty. The Senior Credit Facility is secured by a first priority security interest in the Company’s assets, subject to certain customary exceptions, as well as pledges of its equity interests in certain subsidiaries. The Senior Credit Facility contains financial covenants requiring the Company to (i) maintain an interest coverage ratio (the "Consolidated Interest Coverage Ratio") of not less than 3.00 to 1.00 and (ii) maintain a Consolidated Net Leverage Ratio not to exceed 3.50 to 1.00 provided that the maximum leverage ratio for all periods shall be increased by 0.50 to 1.00 for two consecutive quarters after consummation of a qualified acquisition. The Company may generally make certain investments, redeem debt subordinated to the Senior Credit Facility and make certain restricted payments (such as stock repurchases and dividends) if the Company's Consolidated Net Leverage Ratio does not exceed 3.25 to 1.00 pro forma for such transaction. The Company is otherwise subject to customary covenants including limitations on asset sales, incurrence of additional debt, and limitations on certain investments and restricted payments. The Company was in compliance with its financial and non-financial covenants as of March 31, 2022. 2¼% Convertible Senior Notes The Company adopted the new accounting guidance for convertible instruments effective January 1, 2022, using the modified retrospective method, with the cumulative effect recognized as of January 1, 2022. The primary impact of the new guidance was removing the requirement for the Company to account for beneficial conversion features and cash conversion features in equity, separately from the 2¼% Notes and requires the Company to use the if-converted method for the 2¼% Notes in the diluted earnings per share calculation. See Notes 1 and 2 for additional information. On December 14, 2016, the Company issued $300.0 million aggregate principal amount of 2¼% Notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Holders may convert their 2¼% Notes at their option from April 1, 2022, through June 30, 2022, because the Company's closing stock price exceeded $33.80 for at least 20 days in the 30 day period prior to March 31, 2022. The Company has a stated intention to cash settle the principal amount of the 2¼% Notes with the conversion premium to be settled in common shares. Accordingly, the net balance of the 2¼% Notes of $145.2 million is classified as a current liability as of March 31, 2022. As more fully described in the indenture governing the 2¼% Notes, the holders of the 2¼% Notes may surrender all or any portion of their 2¼% Notes for conversion at any time during any calendar quarter, (and only during such calendar quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% ($33.80) of the conversion price on each applicable trading day. The following table summarizes information regarding the 2¼% Notes (in millions, except years, percentages, conversion rate, and conversion price):
Based on the Company's closing stock price of $39.35 on March 31, 2022, the if-converted value of the 2¼% Notes exceeded the aggregate principal amount of the 2¼% Notes by $74.9 million. The following table presents the interest expense components for the 2¼% Notes:
|
Commitments and Contingencies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies a. Legal Matters The Company and its subsidiaries are subject to legal proceedings, including litigation in U.S. federal and state courts, which arise out of, and are incidental to, the ordinary course of the Company’s on-going and historical businesses. The Company is also subject from time to time to governmental investigations by federal and state agencies. The Company cannot predict the outcome of such proceedings with any degree of certainty. Loss contingency provisions are recorded for probable losses at management’s best estimate of a loss. When only a range of amounts can be reasonably estimated and no amount within the range is more likely than another, the low end of the range is recorded. These estimates are often initially developed substantially earlier than when the ultimate loss is known, and are refined each quarterly reporting period as additional information becomes available. Merger-Related FTC Litigation On January 25, 2022, the U.S. Federal Trade Commission filed a complaint against Lockheed Martin and the Company in the FTC’s administrative court pursuant to Part 3 of the Federal Trade Commission Act. The FTC also filed a complaint in the U.S. District Court for the District of Columbia ("DDC") seeking a Preliminary Injunction to stop the deal pending an administrative trial, which was scheduled to begin on June 16, 2022. The FTC’s administrative complaint alleged that the Merger Agreement constituted an unfair method of competition in violation of Section 5 of the Federal Trade Commission Act and both the administrative complaint and the DDC complaint alleged that the Merger, if consummated, would have substantially lessened competition in relevant markets in violation of Section 7 of the Clayton Act. The administrative complaint sought the following remedies: if the Merger was consummated, divestiture or reconstitution of all associated and necessary assets, in a manner that restores competition in relevant markets; a prohibition against any transaction between the Company and Lockheed Martin that combined the businesses in relevant markets except as approved by the FTC; a requirement that, for a period of time, the Company and Lockheed Martin provide prior notice to the FTC of acquisitions, mergers, consolidations, or any other combinations of their businesses in relevant markets; a requirement to file periodic compliance reports with the FTC; and any other relief appropriate to correct or remedy the anticompetitive effects of the transaction or to restore the Company as a viable, independent competitor in the relevant markets. The Merger Agreement provided that Lockheed Martin could elect to defend against the FTC Litigation within 30 days of the filing of the litigation or terminate the Merger Agreement. On February 13, 2022, Lockheed Martin notified the Company that it had elected to terminate the Merger Agreement. On February 14, 2022, pursuant to the parties’ joint motion, the administrative complaint and DDC complaint were dismissed. Proxy Contest Litigation In early 2022, disagreements relating to the election of directors to the Company’s Board at the Company’s 2022 Annual Meeting of Stockholders (the "Annual Meeting") developed among the Company’s directors. The Company’s eight-member Board was evenly divided between Warren G. Lichtenstein, James R. Henderson, Audrey A. McNiff and Martin Turchin (the "LHMT Directors") and Thomas Corcoran, General Kevin P. Chilton USAF (Ret.), Eileen P. Drake and General Lance W. Lord, USAF (Ret.) (the "CCDL Directors"). On January 28, 2022, SPH Group Holdings LLC (SPH), a company affiliated with Mr. Lichtenstein, nominated a slate of seven directors, including the LHMT Directors, for election. The directors then filed two separate lawsuits in the Court of Chancery of the State of Delaware. On February 7, 2022, the LHMT Directors filed C.A. No. 2022-0127-LWW and on February 11, 2022, the CCDL Directors filed C.A. No. 2022-0146-LWW. The LHMT Complaint The LHMT Directors filed suit against the CCDL Directors and named the Company as a nominal party to the lawsuit. The LHMT Directors sought, among other things: •A declaratory judgment that no CCDL Director nor Aerojet officer, director, employee or anyone else acting or purporting to act on the Company’s behalf may speak on behalf of the Company or take any action on behalf of the Company without proper authorization from the Board or a duly authorized committee of the Board under Delaware law; •A declaratory judgment that, so long as the Board is evenly divided regarding the election at the Annual Meeting, no officer, employee, advisor or agent of the Company shall take action on behalf of the Company for the purpose of directly or indirectly supporting either the LHMT Directors or the CCDL Directors in connection with the election at the Annual Meeting. Instead, so long as the Board is evenly divided in connection with the election, the Company must remain neutral on that subject; •A declaration that alleged actions purportedly taken by the CCDL Directors on behalf of the Company without proper authorization were unauthorized, invalid and void; •A permanent injunction prohibiting the CCDL Directors from taking any action or purporting to take any action on behalf of the Company without proper authorization; and •A permanent injunction specifying that the Company and its officers, employees agents and advisors in their capacity as such shall remain neutral in any electoral dispute between the LHMT Directors and the CCDL Directors. The LHMT Directors also moved for a temporary restraining order, which the CCDL Directors opposed and which would, among other things, prevent the CCDL Directors and Aerojet’s officers, directors, employees, advisors, and agents, without prior written approval of the Board, from (1) making any public statements or disclosures, on behalf of or in the name of the Company in support of the election efforts of any candidate for election at the Annual Meeting and (2) acting on behalf of or in the name of the Company or using Company resources in support of the election efforts of any candidate for election at the Annual Meeting. The CCDL Complaint The CCDL Directors filed suit against the LHMT Directors and SPH, and named the Company as a plaintiff and a nominal defendant in the lawsuit. The LHMT Directors dispute that the CCDL Directors were authorized to name the Company as a plaintiff. The CCDL Directors sought, among other things: •The appointment of a special committee of Gen. Chilton, Mr. Corcoran, and Gen. Lord to manage the Company’s response to the alleged proxy contest launched by the LHMT Directors, or, in the alternative, appointment of a custodian pursuant to 8 Del. C. § 226(a)(2); •A declaration that the LHMT Directors are interested with respect to the alleged proxy contest by virtue of their inclusion in SPH’s nominated slate; •A declaration that the LHMT Directors breached their fiduciary duties by allegedly engaging in unauthorized communications regarding the Lockheed Martin merger and by allegedly participating in discussions regarding, and voting on, matters in which they are self-interested; •A declaration that the LHMT Directors breached their fiduciary duties by allegedly failing to disclose material information about Mr. Lichtenstein’s alleged machinations to take control of Aerojet in their filing with the Securities and Exchange Commission regarding SPH’s nomination of directors and a declaration that the notice on that topic had violated the Company’s advance-notice bylaw for the same reason; and •The removal of Mr. Lichtenstein as a director as a consequence for alleged breaches of his fiduciary duty of loyalty, pursuant to 8 Del. C. § 225(c). Consolidation and Development of the LHMT and CCDL Actions At a hearing on February 15, 2022, the Court of Chancery granted the LHMT Plaintiffs’ motion for a temporary restraining order and ordered the parties to submit a proposed form of order reflecting the Court’s instructions issued during the hearing. The Court also noted the parties’ agreement to consolidate the two separately filed cases, and ordered the parties to submit a proposed order. On February 23, 2022, the Court of Chancery entered a temporary restraining order that provided, among other things, that: •No party to this Action, no officer, director, employee, advisor or agent of the Company, no person or entity purporting to have authority over the Company, and no person or entity acting in concert with any of the foregoing who has notice of this order, shall, absent prior written Board approval (i) make any public statement, issue any press release or make any disclosure on behalf of or in the name of the Company in support of the election efforts of any candidate for election at the Company’s 2022 Annual Meeting, or (ii) take action on behalf of or in the name of the Company or use or otherwise deploy Company funds or other Company resources in support of the election efforts of any candidate for election at the Annual Meeting. •The Company shall retain independent counsel agreed upon and authorized by at least 5 members of the Board in connection with the two actions filed by the directors. On February 25, 2022, the Court of Chancery entered an order consolidating the foregoing actions into one action captioned In Re Aerojet Rocketdyne Holdings, Inc., (Consolidated C.A. No. 2022-0127-LWW), and setting a trial date for the combined actions of May 23-25, 2022. On March 1, 2022, the CCDL Directors nominated a slate of directors for election to the Company’s board. On March 7, 2022, the CCDL Directors dismissed without prejudice the claims they had asserted in the CCDL Complaint. The claims that were purportedly asserted by the Company in the CCDL Complaint remain pending as of March 31, 2022. On March 22, 2022, the Court of Chancery held a hearing on the CCDL Directors’ motion for entry of a final order and judgment and the LHMT Directors’ motions for leave to supplement their complaint and to enforce the Court’s temporary restraining order. The Court denied the CCDL Directors’ motion and granted the LHMT Directors’ motions, ordering that neutral counsel to represent the Company in this action shall be retained, by the agreement of at least 5 members of the Company’s Board, within seven days of this Order. The Company has since retained neutral counsel in accordance with the Court’s orders. Asbestos Litigation The Company has been, and continues to be, named as a defendant in lawsuits alleging personal injury or death and seeking various monetary damages due to exposure to asbestos in building materials, products, or in manufacturing operations. The majority of cases are pending in Illinois state courts. There were 133 asbestos cases pending as of March 31, 2022. Given the lack of any significant consistency to claims (i.e., as to product, operational site, or other relevant assertions) filed against the Company, the Company is generally unable to make a reasonable estimate of the future costs of pending claims or unasserted claims. The aggregate settlement costs and legal and administrative fees associated with the Company’s asbestos litigation has been immaterial for the last three years. As of March 31, 2022, the Company has accrued an immaterial amount related to pending claims. United States ex. rel. Markus vs. Aerojet Rocketdyne Holdings In the case captioned United States ex. rel. Markus vs. Aerojet Rocketdyne Holdings, Inc. et al., Case No. 2:15-CV-02245- WBS-AC, the Department of Justice completed its review of the case and declined to intervene in June 2018. The case was originally filed under seal in the U.S. District Court, Eastern District of California in September 2017 and alleged causes of action against the Company based on false claims, retaliation, and wrongful termination of employment seeking injunctive relief, civil penalties, and compensatory and punitive damages. In February 2019, the Company filed a Motion to Dismiss the False Claims Act ("FCA") counts of the complaint and a Motion to Compel Arbitration on the employment based claims. In May 2019, the court dismissed one count of the FCA claim, denied the motion to dismiss the remaining FCA counts, and moved the employment based claims to arbitration. In September 2021, each party filed a motion for summary judgment. In February 2022, the Court denied Relator’s motion for summary judgment in full and granted the Company’s motion for summary judgment in part. Specifically, the Court rejected Relator’s false certification allegations in their entirety while also significantly diminishing the number of U.S. government contracts at issue in the litigation, which number excludes both the majority of contracts specified in Relator’s Second Amended Complaint ("SAC") as well as numerous contracts regarding which Relator purported to make claims but that were not specified in the SAC. The Court found disputed issues of material fact with regard to the remaining contracts. Trial in this matter commenced on April 26, 2022. On April 27, 2022, the Company agreed to a settlement in principle as to Relator’s remaining FCA claims in the amount of $9.0 million, as well as an attorney’s fee award of $3.0 million. The settlement is subject to final approval by the U.S. Department of Justice. City of Wabash, Indiana v. Aerojet Rocketdyne Holdings On November 15, 2021, a lawsuit entitled City of Wabash, Indiana v. Aerojet Rocketdyne Holdings, Inc., Case No. 3:21-cv-878 was filed in the United States District Court for the Northern District of Indiana against the Company alleging causes of action under the Comprehensive Environmental Response Compensation and Liability Act and the Indiana Environmental Legal Action Statute and seeking damages, reasonable attorneys’ fees and costs. The action was served on the Company on January 11, 2022. The Company will vigorously contest the complaint’s allegations and has not recorded any liability for this matter as of March 31, 2022. b. Environmental Matters The Company is involved in approximately 40 environmental matters under the Comprehensive Environmental Response Compensation and Liability Act, the Resource Conservation Recovery Act, and other federal, state, and local laws relating to soil and groundwater contamination, hazardous waste management activities, and other environmental matters at some of its current and former facilities. The Company is also involved in a number of remedial activities at third party sites, not owned by the Company, where it is designated a potentially responsible party ("PRP") by either the U.S. Environmental Protection Agency ("EPA") and/or a state agency. In many of these matters, the Company is involved with other PRPs. In some instances, the Company’s liability and proportionate share of costs have not been determined largely due to uncertainties as to the nature and extent of site conditions and the Company’s involvement. While government agencies frequently claim PRPs are jointly and severally liable at such sites, in the Company’s experience, interim and final allocations of liability and costs are generally made based on relative contributions of waste or contamination. Anticipated costs associated with environmental remediation that are probable and estimable are accrued. In cases where a date to complete remedial activities at a particular site cannot be determined by reference to agreements or otherwise, the Company projects costs over an appropriate time period not exceeding 15 years. In such cases, generally the Company does not have the ability to reasonably estimate environmental remediation costs that are beyond this period. Factors that could result in changes to the Company’s estimates include completion of current and future soil and groundwater investigations, new claims, future agency demands, discovery of more or less contamination than expected, discovery of new contaminants, modification of planned remedial actions, changes in estimated time required to remediate, new technologies, and changes in laws and regulations. As of March 31, 2022, the aggregate range of these anticipated environmental costs was $293.7 million to $451.2 million and the accrued amount was $293.7 million. See Note 8(c) for a summary of the environmental reserve activity. Of these accrued liabilities, approximately 98% relates to the Company’s U.S. government contracting business, and a portion of this liability is recoverable. The significant environmental sites are discussed below. The balance of the accrued liabilities, which are not recoverable from the U.S. government, relate to other sites for which the Company’s obligations are probable and estimable. Sacramento, California Site In 1989, a federal district court in California approved a Partial Consent Decree ("PCD") requiring Aerojet Rocketdyne, among other things, to conduct a Remedial Investigation and Feasibility Study to determine the nature and extent of impacts due to the release of chemicals from the Sacramento, California site, monitor the American River and offsite public water supply wells, operate Groundwater Extraction and Treatment facilities that collect groundwater at the site perimeter, and pay certain government oversight costs. The primary chemicals of concern for both on-site and off-site groundwater are trichloroethylene, perchlorate, and n-nitrosodimethylamine. A 2002 PCD revision (a) separated the Sacramento site into multiple operable units to allow quicker implementation of remedies for critical areas; (b) required the Company to guarantee up to $75 million (in addition to a prior $20 million guarantee) to assure that Aerojet Rocketdyne’s Sacramento remediation activities are fully funded; and (c) removed approximately 2,600 acres of non-contaminated land from the EPA superfund designation. Obligations under the $75 million aggregate guarantee are limited to $10 million in any year. Both the $75 million aggregate guarantee and the $10 million annual limitation are subject to adjustment annually for inflation. Aerojet Rocketdyne is involved in various stages of soil and groundwater investigation, remedy selection, design, construction, operation and maintenance associated with the operable units, all of which are conducted under the direction and oversight of the EPA, including unilateral administrative orders, and the California Department of Toxic Substances Control ("DTSC") and Regional Water Quality Control Board, Central Valley Region ("RWQCB"). On September 22, 2016, the EPA completed its first five-year remedy review of the Sacramento superfund site. The five-year review required by statute and regulation applies to all remedial actions which result in hazardous substances above levels that allow unlimited use and unrestricted exposure. The Company worked with the EPA to address and remedy the findings of the 2016 five-year remedy review. On September 15, 2021, the EPA issued its second five-year remedy review and concluded that the remedies are functioning as intended for the soil and groundwater contamination and that the vapor intrusion investigation and mitigation activities are protective against vapor intrusion risks. The Company is working with the EPA, DTSC, and RWQCB on the implementation of required onsite land use restrictions. The entire southern portion of the site known as Rio Del Oro was under state orders issued in the 1990s from DTSC and the RWQCB to investigate and remediate soil and groundwater contamination. In 2008, the DTSC released all but approximately 400 acres of the Rio Del Oro property from DTSC’s environmental orders regarding soil contamination although the property remains subject to the RWQCB’s orders to investigate and remediate groundwater environmental contamination emanating offsite from the property. As of March 31, 2022, the estimated range of anticipated costs discussed above for the Sacramento, California site was $215.2 million to $349.2 million and the accrued amount was $215.2 million included as a component of the Company’s environmental reserves. Expenditures associated with this matter are partially recoverable. See Note 8(c) for further discussion on recoverability. Baldwin Park Operable Unit ("BPOU") As a result of its former Azusa, California operations, in 1994, Aerojet Rocketdyne was named a PRP by the EPA in the area of the San Gabriel Valley Basin superfund site known as the BPOU. In 2002, Aerojet Rocketdyne, along with seven other PRPs (the "Cooperating Respondents") signed a project agreement with the San Gabriel Basin Water Quality Authority, the Main San Gabriel Basin Watermaster, and five water companies. The 2002 project agreement terminated in 2017 and the parties executed a project agreement which became operational on May 9, 2017. The agreement has a ten-year term and requires the Cooperating Respondents to fund through an escrow account the ongoing operation, maintenance, and administrative costs of certain treatment and water distribution facilities owned and operated by the water companies. There are also provisions in the project agreement for maintaining financial assurance. Pursuant to the 2017 agreement with the remaining Cooperating Respondents, Aerojet Rocketdyne's current share of future BPOU costs will be approximately 74%. As part of Aerojet Rocketdyne’s sale of its Electronics and Information Systems ("EIS") business to Northrop Grumman Corporation ("Northrop") in October 2001, the EPA approved a prospective purchaser agreement with Northrop to absolve it of a pre-closing liability for contamination caused by the Azusa, California operations, which liability remains with Aerojet Rocketdyne. As part of that agreement, the Company agreed to provide a $25 million guarantee of its obligations under the project agreement. As of March 31, 2022, the estimated range of anticipated costs was $61.6 million to $74.3 million and the accrued amount was $61.6 million included as a component of the Company’s environmental reserves. Expenditures associated with this matter are partially recoverable. See Note 8(c) for further discussion on recoverability. c. Environmental Reserves and Estimated Recoveries Environmental Reserves The Company reviews on a quarterly basis estimated future remediation costs and has an established practice of estimating environmental remediation costs over a fifteen year period, except for those environmental remediation costs with a specific contractual term. Environmental liabilities at the BPOU site are currently estimated through the term of the project agreement, which expires in May 2027. As the period for which estimated environmental remediation costs lengthens, the reliability of such estimates decreases. These estimates consider the investigative work and analysis of engineers, outside environmental consultants, and the advice of legal staff regarding the status and anticipated results of various administrative and legal proceedings. In most cases, only a range of reasonably possible costs can be estimated. In establishing the Company’s reserves, the most probable estimate is used when determinable; otherwise, the minimum amount is used when no single amount in the range is more probable. Accordingly, such estimates can change as the Company periodically evaluates and revises these estimates as new information becomes available. The Company cannot predict whether new information gained as projects progress will affect the estimated liability accrued. The timing of payment for estimated future environmental costs is influenced by a number of factors, such as the regulatory approval process and the time required designing, constructing, and implementing the remedy. The following table summarizes the Company’s environmental reserve activity:
The effect of the final resolution of environmental matters and the Company’s obligations for environmental remediation and compliance cannot be accurately predicted due to the uncertainty concerning both the amount and timing of future expenditures and due to regulatory or technological changes. The Company continues its efforts to mitigate past and future costs through pursuit of claims for recoveries from insurance coverage and other PRPs and continued investigation of new and more cost effective remediation alternatives and associated technologies. Estimated Recoveries On January 12, 1999, Aerojet Rocketdyne and the U.S. government reached a settlement agreement ("Global Settlement") covering environmental costs associated with the Company's Sacramento site and its former Azusa site. Pursuant to the Global Settlement, the Company can recover 88% of its environmental remediation costs through the establishment of prices for Aerojet Rocketdyne's products and services sold to the U.S. government. Additionally, in conjunction with the sale of the EIS business in 2001, Aerojet Rocketdyne entered into an agreement with Northrop (the "Northrop Agreement") whereby Aerojet Rocketdyne is reimbursed by Northrop for a portion of environmental expenditures eligible for recovery under the Global Settlement, subject to an annual billing limitation of $6.0 million and a cumulative limitation of $189.7 million which was reached in June 2017. The following table summarizes the Northrop Agreement activity (in millions):
Environmental remediation costs are primarily incurred by the Company's Aerospace and Defense segment, and certain of these costs are recoverable from the Company's contracts with the U.S. government. The Company currently estimates approximately 12% of its future Aerospace and Defense segment environmental remediation costs will not likely be reimbursable and are expensed. Allowable environmental remediation costs are charged to the Company’s contracts with the U.S. government as the costs are incurred. Because these costs are recovered through forward-pricing arrangements, the ability of Aerojet Rocketdyne to continue recovering these costs from the U.S. government depends on Aerojet Rocketdyne’s sustained business volume from U.S. government contracts and programs. While the Company continues to seek an arrangement with the U.S. government to recover environmental expenditures in excess of the reimbursement ceiling identified in the Global Settlement, there can be no assurances that such a recovery will be obtained, or if not obtained, that such unreimbursed environmental expenditures will not have a materially adverse effect on the Company’s operating results, financial condition, and/or cash flows. Environmental reserves and estimated recoveries impact to unaudited condensed consolidated statements of operations The following table summarizes the financial information for the impact of environmental reserves and recoveries to the unaudited condensed consolidated statements of operations:
d. Arrangements with Off-Balance Sheet Risk As of March 31, 2022, arrangements with off-balance sheet risk consisted of: •$27.8 million in outstanding commercial letters of credit, the majority of which may be renewed, primarily to collateralize obligations for environmental remediation and insurance coverage. •$56.6 million in outstanding surety bonds to primarily satisfy indemnification obligations for environmental remediation coverage •$120.0 million aggregate in guarantees by the Company of Aerojet Rocketdyne’s obligations to U.S. government agencies for environmental remediation activities. •Guarantees, jointly and severally, by the Company’s material domestic subsidiaries of their obligations under the Senior Credit Facility. In addition to the items discussed above, the Company has and will from time to time enter into certain types of contracts that require the Company to indemnify parties against potential third-party and other claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnification to purchasers of its businesses or assets including, for example, claims arising from the operation of the businesses prior to disposition, and liability to investigate and remediate environmental contamination existing prior to disposition; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for claims arising from the use of the applicable premises; and (iii) certain agreements with officers and directors, under which the Company may be required to indemnify such persons for liabilities arising out of their relationship with the Company. The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Additionally, the Company has open purchase orders and other commitments to suppliers, subcontractors, and other outsourcing partners for equipment, materials, and supplies in the normal course of business. These amounts are based on volumes consistent with anticipated requirements to fulfill purchase orders or contracts for product deliveries received, or expected to be received, from customers. A substantial portion of these amounts are recoverable through the Company's contracts with the U.S. government. The Company provides product warranties in conjunction with certain product sales. The majority of the Company’s warranties are a one-year standard warranty for parts, workmanship, and compliance with specifications. On occasion, the Company has made commitments beyond the standard warranty obligation. While the Company has contracts with warranty provisions, there is not a history of any significant warranty claims experience. A reserve for warranty exposure is made on a product by product basis when it is both estimable and probable. These costs are included in the program’s estimate at completion and are expensed in accordance with the Company’s revenue recognition methodology as allowed under GAAP for that particular contract.
|
Retirement Benefits |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits | Retirement Benefits The following table presents the components of retirement benefits expense (income):
|
Operating Segments and Related Disclosures |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Segments and Related Disclosures | Operating Segments and Related Disclosures The Company’s operations are organized into two operating segments based on different products and customer bases: Aerospace and Defense, and Real Estate. The following table presents selected financial information for each reportable segment:
The following table summarizes customers that represented more than 10% of net sales:
|
Unusual Items |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unusual or Infrequent Items, or Both [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unusual Items | Unusual Items The following table presents total unusual items in the unaudited condensed consolidated statements of operations:
In the three months ended March 31, 2022, the Company incurred $16.1 million associated with legal matters. See Note 8(a) for additional information. In the three months ended March 31, 2022, the Company incurred $3.1 million of costs associated with the proxy contest and related litigation costs. See Note 8(a) for additional information. In the three months ended March 31, 2022 and 2021, the Company incurred terminated merger costs of $2.5 million and $7.5 million, respectively. See Note 1 for additional information. The components of the terminated merger costs are as follows (in millions):
In the three months ended March 31, 2021, the Company settled $135.4 million of its 2¼% Notes as a result of receiving conversion notices from the holders of the 2¼% Notes. The principal amount of $135.4 million was settled in cash and the conversion premium was settled in 2.6 million common shares. The Company incurred a pre-tax charge of $9.1 million in the three months ended March 31, 2021, associated with the settlement of the 2¼% Notes.
|
Revision of Previously Issued Financial Statements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Changes and Error Corrections [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revision of Previously Issued Financial Statements | Revision of Previously Issued Financial Statements As disclosed in Note 1, during the three months ended March 31, 2022, the Company identified an immaterial error in its accounting for income taxes associated with its 2¼% Notes. Upon issuance of the 2¼% Notes in 2016, the Company did not record the applicable deferred tax liability associated with the conversion option that had been recorded in other capital, which resulted in an overstatement of other capital, an overstatement of deferred income taxes, an overstatement of other current assets, net and an error in income tax expense in subsequent periods. The Company evaluated the errors and concluded that the errors were not material, either individually or in aggregate, to its current or previously issued consolidated financial statements. Due to the immaterial error related to the accounting for income taxes associated with the 2¼% Notes, the opening other capital balance as of January 1, 2019, 2020, and 2021 was overstated by $20.9 million. Additionally, the opening retained earnings balance as of January 1, 2019 and 2020, was understated by $7.9 million and $8.0 million, respectively, and the opening accumulated deficit as of January 1, 2021, was overstated by $7.8 million. During 2021 income tax expense was overstated by $2.9 million resulting in a cumulative understatement of retained earnings of $10.7 million as of December 31, 2021. There were no changes to the unaudited condensed consolidated statement of operations and condensed consolidated statement of comprehensive income for the three months ended March 31, 2021. The revision to the accompanying unaudited condensed consolidated balance sheet, condensed consolidated statement of stockholders’ equity, and condensed consolidated statement of cash flows are as follows. Condensed Consolidated Balance Sheet
Condensed Consolidated Statements of Stockholders’ Equity
Condensed Consolidated Statement of Cash Flows
|
Basis of Presentation and Nature of Operations (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Nature of Operations | Aerojet Rocketdyne Holdings, Inc. ("Aerojet Rocketdyne Holdings" or the "Company") has prepared the accompanying unaudited condensed consolidated financial statements, including the accounts of the Company and its 100% owned and majority owned subsidiaries, in accordance with the instructions to Form 10-Q. The December 31, 2021, condensed consolidated balance sheet was derived from audited financial statements, but does not include all of the disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). These interim financial statements should be read in conjunction with the financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Certain reclassifications have been made to financial information for prior years to conform to the current year’s presentation. The Company believes the accompanying unaudited condensed consolidated financial statements reflect all adjustments, including normal recurring accruals, necessary for a fair statement of its financial position, results of operations, and cash flows for the periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In addition, the operating results for interim periods may not be indicative of the results of operations for a full year. The Company’s operations are organized into two segments: Aerospace and Defense — includes the operations of the Company’s wholly-owned subsidiary Aerojet Rocketdyne, Inc. ("Aerojet Rocketdyne"), a leading technology-based designer, developer and manufacturer of aerospace and defense products and systems for the United States ("U.S.") government, including the Department of Defense ("DoD"), the National Aeronautics and Space Administration ("NASA"), and major aerospace and defense prime contractors. Real Estate — includes the activities of the Company’s wholly-owned subsidiary Easton Development Company, LLC ("Easton") related to the re-zoning, entitlement, sale, and leasing of the Company’s excess real estate assets.
|
Fiscal Period, Policy | The fiscal year of the Company's subsidiary, Aerojet Rocketdyne, ends on the last Saturday in December. |
Recently Issued Accounting Pronouncements | Recently Issued Accounting PronouncementsIn August 2020, the Financial Accounting Standards Board issued guidance which simplifies the accounting for convertible instruments. This guidance eliminates certain models that require separate accounting for embedded conversion features, in certain cases. Additionally, among other changes, the guidance eliminates certain of the conditions for equity classification for contracts in an entity’s own equity. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The Company adopted the new guidance as of January 1, 2022, using the modified retrospective approach resulting in the following adjustment (i) a decrease of $1.9 million in deferred tax liabilities, (ii) a decrease of $5.6 million in other capital, (iii) a decrease of $1.0 million in retained earnings, and (iv) an increase of $8.5 million in debt. |
Revenue Recognition | Revenue RecognitionIn the Company’s Aerospace and Defense segment, the majority of revenue is earned from long-term contracts to design, develop, and manufacture aerospace and defense products for, and provide related services to, the Company’s customers, including the U.S. government and major aerospace and defense prime contractors.In the Company’s Aerospace and Defense segment, the timing of revenue recognition, customer invoicing, and collections produces accounts receivable, contract assets, and contract liabilities in the unaudited condensed consolidated balance sheets. |
Environmental Reserves | Environmental Reserves The Company reviews on a quarterly basis estimated future remediation costs and has an established practice of estimating environmental remediation costs over a fifteen year period, except for those environmental remediation costs with a specific contractual term. Environmental liabilities at the BPOU site are currently estimated through the term of the project agreement, which expires in May 2027. As the period for which estimated environmental remediation costs lengthens, the reliability of such estimates decreases. These estimates consider the investigative work and analysis of engineers, outside environmental consultants, and the advice of legal staff regarding the status and anticipated results of various administrative and legal proceedings. In most cases, only a range of reasonably possible costs can be estimated. In establishing the Company’s reserves, the most probable estimate is used when determinable; otherwise, the minimum amount is used when no single amount in the range is more probable. Accordingly, such estimates can change as the Company periodically evaluates and revises these estimates as new information becomes available. The Company cannot predict whether new information gained as projects progress will affect the estimated liability accrued. The timing of payment for estimated future environmental costs is influenced by a number of factors, such as the regulatory approval process and the time required designing, constructing, and implementing the remedy.
|
Earnings Per Share ("EPS") of Common Stock (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Reconciliation of Numerator and Denominator Used to Calculate Basic and Diluted Income (Loss) Per Share of Common Stock | The following table reconciles the numerator and denominator used to calculate basic and diluted EPS of common stock:
|
Revenue Recognition (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Impact of Contracts in Progress on Statement of Operations | The following table summarizes the impact of the changes in significant contract accounting estimates on the Company’s Aerospace and Defense segment operating results:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Contract Asset and Liability | The following table summarizes contract assets and liabilities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedules of Percentage of Net Sales by Contract and Customer Type | The following table summarizes the percentages of net sales by contract type:
The principal end user customers are primarily agencies of the U.S. government as illustrated in the following table:
|
Stock-Based Compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Stock-Based Compensation Expense by Type of Award | The following table summarizes stock-based compensation by type of award:
|
Balance Sheet Accounts (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value of Financial Instruments |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Estimated Fair Value and Principal Amount of Outstanding Debt | The following table summarizes the estimated fair value and principal amount for outstanding debt obligations excluding finance lease obligations:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accounts Receivable | Accounts Receivable
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Current Assets | Other Current Assets
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Property, Plant and Equipment, net | Property, Plant and Equipment, net
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Noncurrent Assets | Other Noncurrent Assets
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Current Liabilities | Other Current Liabilities
|
Income Taxes (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Income Tax Provision |
|
Long-term Debt (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Long-Term Debt |
The following table summarizes information regarding the 2¼% Notes (in millions, except years, percentages, conversion rate, and conversion price):
The following table presents the interest expense components for the 2¼% Notes:
|
Commitments and Contingencies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Environmental Reserve Activity | The following table summarizes the Company’s environmental reserve activity:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Northrop Agreement Activity | The following table summarizes the Northrop Agreement activity (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Financial Information for the Impact of Environmental Reserves and Recoveries | The following table summarizes the financial information for the impact of environmental reserves and recoveries to the unaudited condensed consolidated statements of operations:
|
Retirement Benefits (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Components of Retirement Benefit Expense (Benefit) | The following table presents the components of retirement benefits expense (income):
|
Operating Segments and Related Disclosures (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Selected Financial Information for Each Reportable Segment | The following table presents selected financial information for each reportable segment:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Customers that Represented More than 10% of Net Sales | The following table summarizes customers that represented more than 10% of net sales:
|
Unusual Items (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unusual or Infrequent Items, or Both [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Unusual Items Expense | The following table presents total unusual items in the unaudited condensed consolidated statements of operations:
|
Revision of Previously Issued Financial Statements (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Changes and Error Corrections [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Error Corrections and Prior Period Adjustments | The revision to the accompanying unaudited condensed consolidated balance sheet, condensed consolidated statement of stockholders’ equity, and condensed consolidated statement of cash flows are as follows. Condensed Consolidated Balance Sheet
Condensed Consolidated Statements of Stockholders’ Equity
Condensed Consolidated Statement of Cash Flows
|
Earnings Per Share ("EPS") of Common Stock - Reconciliation of Numerator and Denominator (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Numerator: | ||
Net income | $ 27.8 | $ 18.1 |
Income allocated to participating securities | (0.1) | (0.1) |
Net income for basic EPS | 27.7 | 18.0 |
Interest on 2¼% Notes | 0.7 | 0.0 |
Net income for diluted EPS | $ 28.4 | $ 18.0 |
Denominator: | ||
Basic weighted average shares (in shares) | 80.2 | 77.6 |
Effect of: | ||
2 1/4% Notes (in shares) | 5.6 | 3.1 |
Diluted weighted average shares (in shares) | 85.8 | 80.7 |
Basic | ||
Basic earnings per share (in dollars per share) | $ 0.34 | $ 0.23 |
Diluted | ||
Diluted earnings per share (in dollars per share) | $ 0.33 | $ 0.22 |
Convertible Debt | 2 1/4% Notes | ||
Diluted | ||
Debt instrument interest rate stated percentage | 2.25% |
Revenue Recognition - Schedule of Contract Asset and Liability (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Revenue from Contract with Customer [Abstract] | ||
Contract assets | $ 378.6 | $ 359.6 |
Reserve for overhead rate disallowance | (6.6) | (5.4) |
Contract assets, net of reserve | 372.0 | 354.2 |
Contract liabilities | 366.7 | 366.5 |
Net contract assets (liabilities), net of reserve | $ 5.3 | $ (12.3) |
Revenue Recognition - Schedule of Percentage of Sales by Contract and Customer (Details) - Sales Revenue, Net |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Contract | Fixed-price | ||
Concentration Risk [Line Items] | ||
Percentage of net sales | 56.00% | 51.00% |
Contract | Cost-reimbursable | ||
Concentration Risk [Line Items] | ||
Percentage of net sales | 44.00% | 49.00% |
Customers | U.S. government | ||
Concentration Risk [Line Items] | ||
Percentage of net sales | 95.00% | 97.00% |
Customers | Non U.S. government | ||
Concentration Risk [Line Items] | ||
Percentage of net sales | 5.00% | 3.00% |
Segment Concentration Risk | Real Estate | ||
Concentration Risk [Line Items] | ||
Percentage of net sales | 1.00% | 1.00% |
Balance Sheet Accounts - Schedule of Estimated Fair Value and Principal Amount of Outstanding Debt (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Debt Instrument [Line Items] | ||
Fair Value | $ 499.7 | $ 541.9 |
Principal Amount | 421.5 | 428.1 |
Term loan | ||
Debt Instrument [Line Items] | ||
Fair Value | 269.8 | 275.8 |
Principal Amount | 275.6 | 282.2 |
2 1/4% Notes | ||
Debt Instrument [Line Items] | ||
Fair Value | 229.9 | 266.1 |
Principal Amount | $ 145.9 | $ 145.9 |
Convertible Debt | 2 1/4% Notes | ||
Debt Instrument [Line Items] | ||
Debt instrument interest rate stated percentage | 2.25% |
Balance Sheet Accounts - Schedule of Accounts Receivable (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Billed receivables under long-term contracts | $ 143.2 | $ 60.3 |
Other trade receivables | 0.2 | 0.3 |
Accounts receivable | $ 143.4 | $ 60.6 |
Balance Sheet Accounts - Schedule of Other Current Assets (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Deferred costs recoverable from the U.S. government | $ 40.4 | $ 37.4 |
Income tax receivable | 0.0 | 13.8 |
Inventories | 11.1 | 10.0 |
Prepaid expenses | 15.5 | 15.3 |
Other | 26.6 | 23.0 |
Other current assets | $ 93.6 | $ 99.5 |
Balance Sheet Accounts - Schedule of Property, Plant and Equipment, net (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | $ 1,126.6 | $ 1,123.2 |
Less: accumulated depreciation | (713.3) | (702.1) |
Property, plant and equipment, net | 413.3 | 421.1 |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | 71.1 | 71.1 |
Buildings and improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | 505.1 | 503.0 |
Machinery and equipment, including capitalized software | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | 501.6 | 499.1 |
Construction-in-progress | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | $ 48.8 | $ 50.0 |
Balance Sheet Accounts - Schedule of Other Noncurrent Assets (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Real estate held for entitlement and leasing | $ 103.8 | $ 103.7 |
Deferred costs recoverable from the U.S. government | 62.2 | 62.1 |
Receivable from Northrop Grumman Corporation for environmental remediation costs | 33.0 | 34.5 |
Other | 37.3 | 43.0 |
Other noncurrent assets | $ 236.3 | $ 243.3 |
Balance Sheet Accounts - Schedule of Other Current Liabilities (Details) - USD ($) $ in Millions |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Accrued compensation and employee benefits | $ 103.5 | $ 122.0 |
Income taxes payable | 42.7 | 0.0 |
Other | 66.9 | 50.7 |
Other current liabilities | $ 213.1 | $ 172.7 |
Balance Sheet Accounts - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Income taxes payable | $ 42.7 | $ 0.0 |
Income tax receivable | $ 0.0 | $ 13.8 |
Environmental remediation costs, new standard amortization period (years) | 5 years |
Income Taxes (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
|
Income Tax Disclosure [Abstract] | |||
Income tax provision | $ 10.5 | $ 5.6 | $ 2.9 |
Effective income tax rate | 27.40% | 23.60% | |
Effective income tax rate, federal statutory rate | 21.00% | 21.00% |
Long-term Debt - 2.25% Convertible Senior Notes (Details) |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022
USD ($)
trading_day
$ / shares
|
Dec. 31, 2021
USD ($)
|
Dec. 14, 2016
USD ($)
|
|
Debt Instrument [Line Items] | |||
Current portion of long-term debt | $ 177,300,000 | $ 166,700,000 | |
Share price (in USD per share) | $ / shares | $ 39.35 | ||
Convertible Debt | 2 1/4% Notes | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 300,000,000 | ||
Debt instrument interest rate stated percentage | 2.25% | ||
Debt convertible trigger stock price (in USD per share) | $ / shares | $ 33.80 | ||
Debt convertible threshold trading days | trading_day | 20 | ||
Debt convertible threshold consecutive trading days | trading_day | 30 | ||
Current portion of long-term debt | $ 145,200,000 | ||
Convertible debt threshold percentage of stock price trigger | 130.00% | ||
Debt Component of Convertible Debt | 2 1/4% Notes | |||
Debt Instrument [Line Items] | |||
If-converted value in excess of principal | $ 74,900,000 |
Long-term Debt - Schedule of 2.25% Convertible Senior Notes (Details) |
3 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Mar. 31, 2022
$ / shares
|
Mar. 31, 2021 |
Dec. 31, 2021
$ / shares
|
Mar. 10, 2021
$ / shares
|
Dec. 20, 2020
$ / shares
|
|
Debt Instrument [Line Items] | |||||
Conversion price (in USD per share) | $ 51.00 | $ 56.00 | |||
2 1/4% Notes | |||||
Debt Instrument [Line Items] | |||||
Remaining amortization period (years) | 1 year 9 months | 2 years | |||
Effective interest rate (as a percent) | 2.60% | 5.80% | |||
Common stock conversion rate (in shares per USD) | 0.0384615 | 0.0384615 | |||
Conversion price (in USD per share) | $ 26.00 | $ 26.00 |
Long-Term Debt - Interest Expense Components for the 2¼% Notes (Details) - 2 1/4% Notes - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Debt Instrument [Line Items] | ||
Interest expense-contractual interest | $ 0.8 | $ 0.8 |
Interest expense-amortization of debt discount (see discussion above) | 0.0 | 1.1 |
Interest expense-amortization of deferred financing costs | $ 0.1 | $ 0.1 |
Commitments and Contingencies - Narrative - Legal Matters (Details) $ in Millions |
Apr. 27, 2022
USD ($)
|
Mar. 31, 2022
legal_matter
|
---|---|---|
Asbestos Litigation | ||
Loss Contingencies [Line Items] | ||
Unresolved asbestos cases pending | legal_matter | 133 | |
United States Ex. Rel. Markus Vs. Aerojet Rocketdyne Holdings | Pending Litigation | Subsequent Event | ||
Loss Contingencies [Line Items] | ||
Settlement in principle, amount | $ 9.0 | |
Attorney's fees | $ 3.0 |
Commitments and Contingencies - Narrative - Environmental Reserves and Estimated Recoveries (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2022
USD ($)
| |
Site Contingency [Line Items] | |
Environmental remediation cost expected period (years) | 15 years |
Non-reimbursable percentage of environmental costs | 12.00% |
Northrop | |
Site Contingency [Line Items] | |
Percentage of environmental remediation costs recoverable | 88.00% |
Current annual billing limitation | $ 6.0 |
Reimbursable remediation cost | $ 189.7 |
Commitments and Contingencies - Summary of Northrop Agreement Activity (Details) - Northrop $ in Millions |
Mar. 31, 2022
USD ($)
|
---|---|
Contingencies And Commitments [Line Items] | |
Total reimbursable costs under the Northrop Agreement | $ 189.7 |
Amount reimbursed to the Company through March 31, 2022 | (150.7) |
Receivable from Northrop included in the unaudited balance sheet at March 31, 2022 | $ 39.0 |
Commitments and Contingencies - Summary of Financial Information for the Impact of Environmental Reserves and Recoveries (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Commitments and Contingencies Disclosure [Abstract] | ||
Expense to unaudited condensed consolidated statements of operations | $ 0.4 | $ 0.5 |
Commitments and Contingencies - Arrangements with Off-Balance Sheet Risk (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2022
USD ($)
| |
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | |
Outstanding surety bonds | $ 56.6 |
Guarantee obligations | $ 120.0 |
Product warranty period | 1 year |
Letter of credit | Line of credit | |
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items] | |
Letters of credit outstanding | $ 27.8 |
Retirement Benefits - Schedule of Components of Retirement Benefit Expense (Income) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Pension Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Interest cost on benefit obligation | $ 8.9 | $ 8.4 |
Expected return on assets | (15.7) | (15.3) |
Amortization of net losses (gains) | 7.7 | 15.9 |
Retirement benefits expense (income) | 0.9 | 9.0 |
Postretirement Medical and Life Insurance Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Interest cost on benefit obligation | 0.1 | 0.1 |
Expected return on assets | 0.0 | 0.0 |
Amortization of net losses (gains) | (0.7) | (0.6) |
Retirement benefits expense (income) | $ (0.6) | $ (0.5) |
Operating Segments and Related Disclosures - Narrative (Details) |
3 Months Ended |
---|---|
Mar. 31, 2022
segment
| |
Segment Reporting [Abstract] | |
Number of operating segments | 2 |
Operating Segments and Related Disclosures - Summary of Customers that Represented More than 10% of Net Sales (Details) - Customers - Sales Revenue, Net |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Lockheed Martin | ||
Revenue, Major Customer [Line Items] | ||
Percentage of net sales | 34.00% | 27.00% |
NASA | ||
Revenue, Major Customer [Line Items] | ||
Percentage of net sales | 18.00% | 26.00% |
Raytheon Technologies Corporation | ||
Revenue, Major Customer [Line Items] | ||
Percentage of net sales | 17.00% | 15.00% |
Unusual Items - Summary of Unusual Items Expense (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Unusual or Infrequent Item [Line Items] | ||
Loss on debt | $ 0.0 | $ 9.1 |
Unusual Items | ||
Unusual or Infrequent Item [Line Items] | ||
Legal matters (component of other expense, net) | 16.1 | 0.0 |
Proxy contest and related litigation costs (component of other expense, net) | 3.1 | 0.0 |
Terminated merger costs (component of other expense, net) | 2.5 | 7.5 |
Loss on debt | 0.0 | 9.1 |
Total unusual items | $ 21.7 | $ 16.6 |
Unusual Items - Narrative (Details) - USD ($) shares in Millions, $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Debt Instrument [Line Items] | ||
Loss on debt | $ 0.0 | $ (9.1) |
2 1/4% Notes | Convertible Debt | ||
Debt Instrument [Line Items] | ||
Extinguishment of debt | $ 135.4 | |
Converted instrument, shares settled (in shares) | 2.6 | |
Debt instrument interest rate stated percentage | 2.25% | |
Loss on debt | $ (9.1) | |
Unusual Items | ||
Debt Instrument [Line Items] | ||
Legal matters (component of other expense, net) | 16.1 | 0.0 |
Proxy contest and related litigation costs (component of other expense, net) | 3.1 | 0.0 |
Terminated merger costs (component of other expense, net) | 2.5 | 7.5 |
Loss on debt | $ 0.0 | $ (9.1) |
Unusual Items - Schedule of Merger Costs (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Unusual or Infrequent Item [Line Items] | ||
Gain on legal matters and settlements | $ 2.5 | $ 7.5 |
Legal | ||
Unusual or Infrequent Item [Line Items] | ||
Gain on legal matters and settlements | 1.8 | 4.6 |
Employee compensation | ||
Unusual or Infrequent Item [Line Items] | ||
Gain on legal matters and settlements | 0.3 | 2.1 |
Consulting and other professional costs | ||
Unusual or Infrequent Item [Line Items] | ||
Gain on legal matters and settlements | $ 0.4 | $ 0.8 |
Revision of Previously Issued Financial Statements - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Jan. 01, 2021 |
Jan. 01, 2020 |
Jan. 01, 2019 |
|
Reclassification [Line Items] | ||||||
Other capital | $ 572.7 | $ 578.1 | $ 20.9 | $ 20.9 | $ 20.9 | |
Retained earnings | 129.4 | 102.6 | $ (7.8) | $ 8.0 | $ 7.9 | |
Income tax provision | $ 10.5 | $ 5.6 | 2.9 | |||
Reclassifications due to Adoption | ||||||
Reclassification [Line Items] | ||||||
Other capital | (20.9) | |||||
Retained earnings | $ 10.7 |
/@M+X_#\7SX$@(_1D^.T9/.'_5%OY>2MQI]4 K"##BD1X>T
6N7NRY!F!I#IY@79&R/)5[9U,<3[]'&/)EJQ
M3*+%4UZI#[SJHKH3%T6.YI]N80D'(Z2:N&BE*0RM(4_ % E#OH%1(MH(XHF7
M*($K3I%DJ^=JX=A8)Z?96/O: ?WBQ#!8%5$'J6/GS+]=I0$S%P<^O)^Y>QP?
M9H[]/(J1Z*@?3L84[RT9J[:[; RD>,5,]VWT9N$ 1"T]6,4'6M=M'8SW_&!8YB'\&\
MDCM=[0R&,FX7<@;"I\FLR]@VPJFPRYT_O9ZTXZ@L2]=:-K+S]P4\K^Y,3]%>
M 2V*%NV2IPQ%4X; C% NNB&!?D[$(7;"1AN3:I^HNHS$ 1$6U.ID0PC#D?@%
MTVYK:[ERGAW?1N^)IYUWCURR6!ZDP /U#4FNF\3SW
M4A=L0S?+PDQK)I?HQU]GN;&:KLFW(\$&7;"!#S;X#^=Z%,E5Y /#KAKVD]3LY.1\GD9#)Y9+XSO]\SGN_LC^PW
M>6.;K*B:KC;)?UY/F[8FHOFO1U8]]ZN>\ZKG_RPL/SH=&/55LTHS\\,!<6)C
MZK4Y>&)GZ3AY;^9ID?R:MJVIF^33PM CRU5:;OAQ2\.:;MK8W*8UCR DT!=?
MB'V2MDH*'KVJJ\R8G.9M1HDMLZ+#YZ2PK9VGS&:V3'X?WXV3F B2 @J)WO
M@BUJH&+_#FEC:UNWG>,B6XOOTFB DY \F21$31Q)YRK P_3(%TSE@S.2
M?7,5PA*W5B"*PB@&2R X+'%,]+4G1)I$BS5(0H(;7E6X=G?>:(:B1'A!*?3U
M=\GA]"C2"Y&NQZTHY+TB[DAKK5@07UYX*7P(]T-OOY"PCU0&/9OX:$L8?R3I
M/TD$XJBW^2?$XL+N8WLA-JAJPY%1J9-!82G7Q6='4IAH\H%8GHQ>G)S0!+6$
M(4HZYJ")V6R'$> XA/P1$+6I9QQQ4R^(U /=B 9FB< 5O(%[?MTV]WJO*);,Q^G''*]L$
M:JW1I%#;7K?OB"QAZ\H#]@=H#D'5&@)_L-?]Y-H#/ XVF5<&M7.!A2T'F#_P
M?N/^2O%LOWG[-&_$_(@C[7:H/9&?D%^JR(]\F/4L\OLC/MNS)[?A**0D#U5,
MG?[Q#T4=N-ZHZSD22M@&RUVV_ERN612#\9AM:WL#PL7!:(",^UY(*"*\VWSD
MU>L/B,"NZ\SHDF&S[!/RNDQJC DJK\; [*'%:&H7IGLY%Z,CBP9J"<5W%!
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M.JV@9*81_=^FTYO!4[$ZL%LB/E1[U86)KBEQ/BGN "P;GOC ?<(<]E;?]KZE%)HPUOGJ(I),$8$ ,MV]+%TMGB&
MXEKU&2$$)-6*OE(,[Q>*[Q4)%(:T!V^6)N>B7$H_X;'!<->-;KC7K#25DG_
MV;FF;%64'\CS'W=D9!I0;+O1;^(S['6&QDN'R/H=T#C_&HF/G-7.,)O^
MAKZKG/>^4)7*;?@['+$@M(H?J[JGW:>^Z_B%ZS \?B?\F<\)Z;!OC:DS)-!(
MN/CM+=X$N^/O72L;L*WAGULE43%H -ZO+4+4W- "W0?0-_\!4$L#!!0 (
M $>?HU2;RZLP,"@ -[ 9 >&PO=V]R:W-H965T?7GEJ/7NXR_)SW75K9)?Z'S8(WG__B8YI.\) C'76*#,P)NLX%C0_5H/
M\596PBPP\II"?8L&R _G%KN1@+*/+5$
*U=I/4<3*&Q
MCZYTW9Q\%KZLGN:$GXUUS$.K*@5G YJ3?L*HIFL IVY4+,[/;')%!I1K2TUF
M-6=<87ZQ2F5D<(2$FQ"*C4K!M<8)"JNB3TO3A%)LN1,&\X!F&)@*(W'W:'ZF
M8-&?!=C,!ZG[B-6H ,$18A1+=*IYOTL8A^:M=&J0?
M>T48LTR >]/[1^3L,%AXF2](N)!I];5!JR!?,F7C";>C#T!P(UCTJ 8HB=('
M,A?:'L5CI+:\&BXV< .#D2E>)DRAE<)AI1V%'DICS#%W,//(I% *<]T6>OK&
M@U#;"(7$>84#NM0DT9T](^R$R<. ]':M<_V['7B
S:.B0OOFB)-2Y+<;1^IN6$PR@I/E."]6I@,5?-;+2P3Z'J/7H%J>@HZ%[:(
MM9C8+N[/^9ZQ)=D"(IBU)V;662,E*31;PGBLS3#V!::%:5;&)DHXKX=K)>
M\I
3@XCO=/XH@V^!6?!-S8
MSC6CHRRT_DPW9\7A("*+0$+N2 3'X1I.04J2A'9\:80.6IVTL7M]+_V-/SP>
M9L$MG&KYMRC<^G P&[ "EKR6[D+?_ G-@<8D+]?2^G]VTZR-!BROK=-ELQDM
M*(4*([]M@'C*AJ39D'B[@R)OY2ON^-&!T3?,T&J41A?^J'XW&B<4>>72&9P5
MN,\=G7#)50[LTH? <9[K6CG+7ESQA02[>S!RJ(26CO)&X$D0F#PB,&7OM')K
MRUZK HJ'^T=H7&MA
&]F+Z"',H%
M6M7 &O_/L,YFPTEG_!E84__[(:SI>!BULP]NMH(Z"7^/@9JA!(J#+&KB@@1N
MK.[)L'&;8>,G9]AKZP2R.6+0R;60^ )SK4*3CDMB05K\H7;6X:10*W3?PFW+
MO5[5VW/O:@ULJ2661!+LO(=#711?$3)T/X/6S.4FILC,JC63!S.Q-#/=L;-
M.YE>2+'R'&89W.:R]E-+SR? ),8F=-?L=\'X#HAOR.#[./[A@H?A>P6F9%)S
MA5Y.)G.?2